Yichang HEC privatization advances, long-stop date extended

The proposed pre-conditional privatization of Yichang HEC ChangJiang Pharmaceutical Co., Ltd. (HKEX:1558) by Sunshine Lake Pharma Co., Ltd. is moving forward. A joint announcement indicates partial fulfillment of a pre-condition, specifically related to approvals and filings for the listing of Offeror H Shares on the Stock Exchange, and the CSRC has concluded its filing procedure and published the relevant filing results on its website on June 17, 2025. While approvals from NDRC, MoC and SAFE have already been obtained, only the approval of the Listing Committee of the Stock Exchange remains outstanding.